Publication Name	World Journal of Clinical Cases
Manuscript ID	79704
Country	Egypt

Received	2022-09-02 15:22
Peer-Review Started	2022-09-02 15:26
To Make the First Decision
Return for Revision	2023-01-05 07:48
Revised	2023-01-20 15:26
Second Decision	2023-03-08 03:01
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-03-09 07:15
Articles in Press	2023-03-09 07:15
Publication Fee Transferred
Edit the Manuscript by Language Editor	2023-02-14 02:13
Typeset the Manuscript	2023-03-19 12:16
Publish the Manuscript Online	2023-03-30 13:19

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Diagnosis, treatment protocols, and outcomes of liver transplant recipients infected with COVID-19
Manuscript Source	Invited Manuscript
All Author List	Mai Hashem and Mohamed El-Kassas
ORCID	Author(s) ORCID Number Mohamed El-Kassas http://orcid.org/0000-0002-3396-6894
Funding Agency and Grant Number
Corresponding Author	Mohamed El-Kassas, MD, Professor, Endemic Medicine Department, Faculty of Medicine, Helwan University, Ain Helwan, Helwan, Cairo 11795, Egypt. m_elkassas@hq.helwan.edu.eg
Key Words	COVID-19; Liver transplantation; Recipient; Protocols; Outcomes
Core Tip	Liver transplant (LT) patients infected with severe acute respiratory syndrome coronavirus 2 have clinical, biochemical, and radiological features highly comparable to those of immunocompetent patients, except for a higher incidence of gastrointestinal symptoms. The prognosis of LT recipients is similar to non-LT patients and is not significantly affected by immunosuppression but rather by comorbidities. Considering the risk of organ rejection, it may not be wise to stop all immunosuppression after a coronavirus disease 2019 diagnosis. All LT recipients should be vaccinated, considering booster doses augment vaccination immunogenicity. Still, a considerable proportion of patients remain at risk for coronavirus disease 2019. Therefore, social isolation and other precautions must be maintained.
Publish Date	2023-03-30 13:19
Citation	Hashem M, El-Kassas M. Diagnosis, treatment protocols, and outcomes of liver transplant recipients infected with COVID-19. World J Clin Cases 2023; 11(10): 2140-2159
URL	https://www.wjgnet.com/2307-8960/full/v11/i10/2140.htm
DOI	https://dx.doi.org/10.12998/wjcc.v11.i10.2140

Full Article (PDF)	WJCC-11-2140.pdf
Full Article (Word)	WJCC-11-2140.docx
Manuscript File	79704_Auto_Edited-FilipodiaCL-JLW.docx
Answering Reviewers	79704-Answering reviewers.pdf
Audio Core Tip	79704-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	79704-Conflict-of-interest statement.pdf
Copyright License Agreement	79704-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	79704-Language certificate.pdf
Peer-review Report	79704-Peer-review(s).pdf
Scientific Misconduct Check	79704-Bing-Liu GL-2.png
Scientific Editor Work List	79704-Scientific editor work list.pdf